Christopher Longshaw

Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID)

Kerrie Davies, Christopher Longshaw, Georgina Davis et al. · The Lancet Infectious Diseases · 2014 · 340 citations

Antibiotics, Clostridium Difficile, Clostridium Difficile Infection +9

Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes

Jane Freeman, Jon J. Vernon, K. Morris et al. · Clinical Microbiology and Infection · 2014 · 264 citations · Full text

Antimicrobial Resistance Gene, Antimicrobial Susceptibility, Antibiotics +9

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

Benoît Guéry, Francesco Menichetti, Veli-Jukka Anttila et al. · The Lancet Infectious Diseases · 2017 · 208 citations · Full text

Patients 60, Antimicrobial Susceptibility, Antibiotics +7

Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013

Kerrie Davies, Helen Ashwin, Christopher Longshaw et al. · Eurosurveillance · 2016 · 178 citations · Full text

The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011–2014

Jane Freeman, Jon J. Vernon, Sally Pilling et al. · Clinical Microbiology and Infection · 2017 · 134 citations

Antimicrobial Susceptibility, Antibiotics, Medicine +8